Dicerna Pharmaceuticals Inc (OQ:DRNA)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for DRNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Jan 25/19 Jan 25/19 Kozin Marc D Indirect Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jan 25/19 Jan 23/19 Protopapas Anna Direct Ownership Director Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,000  
Jan 25/19 Jan 23/19 Kozin Marc D Direct Ownership Director Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,000  
Jan 4/19 Jan 2/19 Green John B Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 180,000  
Jan 4/19 Jan 2/19 Fambrough Douglas Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 505,000  
Jan 4/19 Jan 2/19 Weissman James B Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 180,000  
Jan 4/19 Jan 2/19 Brown Bob D Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 180,000  
Jan 4/19 Jan 2/19 Rosskamp Ralf Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 180,000  
Nov 9/18 Nov 8/18 Kolchinsky Peter Indirect Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -107,920 $14.86
Nov 9/18 Nov 7/18 Kolchinsky Peter Indirect Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -250,000 $14.74
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for DRNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Feb 8/19 Aug 31/18 Fambrough Douglas Indirect Ownership Employee Stock Option (right to buy) Form 5 : Annual Statement of Beneficial Ownership of Securities 200,000  
Feb 8/19 Aug 31/18 Fambrough Douglas Indirect Ownership Employee Stock Option (right to buy) Form 5 : Annual Statement of Beneficial Ownership of Securities 200,000  
Feb 8/19 Aug 31/18 Fambrough Douglas Direct Ownership Employee Stock Option (right to buy) Form 5 : Annual Statement of Beneficial Ownership of Securities -200,000  
Feb 8/19 Aug 31/18 Fambrough Douglas Direct Ownership Employee Stock Option (right to buy) Form 5 : Annual Statement of Beneficial Ownership of Securities -200,000  
Jan 25/19 Jan 23/19 Protopapas Anna Direct Ownership Director Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,000  
Jan 25/19 Jan 23/19 Kozin Marc D Direct Ownership Director Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,000  
Jan 25/19 Jan 25/19 Kozin Marc D Indirect Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jan 4/19 Jan 2/19 Green John B Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 180,000  
Jan 4/19 Jan 2/19 Fambrough Douglas Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 505,000  
Jan 4/19 Jan 2/19 Weissman James B Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 180,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $DRNA

StockTwits